{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T18:27:09Z","timestamp":1781893629110,"version":"3.54.5"},"reference-count":44,"publisher":"Portland Press Ltd.","issue":"6","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,3,1]]},"abstract":"<jats:p>The metabolic disorders that predispose patients to NASH (non-alcoholic steatohepatitis) include insulin resistance and obesity. Repeated hypoxic events, such as occur in obstructive sleep apnoea syndrome, have been designated as a risk factor in the progression of liver disease in such patients, but the mechanism is unclear, in particular the role of hypoxia. Therefore we studied the influence of hypoxia on the development and progression of steatohepatitis in an experimental mouse model. Mice with a hepatocellular-specific deficiency in the Pten (phosphatase and tensin homologue deleted on chromosome 10) gene, a tumour suppressor, were exposed to a 10% O2 (hypoxic) or 21% O2 (control) atmosphere for 7\u00a0days. Haematocrit, AST (aspartate aminotransferase), glucose, triacylglycerols (triglycerides) and insulin tolerance were measured in blood. Histological lesions were quantified. Expression of genes involved in lipogenesis and mitochondrial \u03b2-oxidation, as well as FOXO1 (forkhead box O1), hepcidin and CYP2E1 (cytochrome P450 2E1), were analysed by quantitative PCR. In the animals exposed to hypoxia, the haematocrit increased (60\u00b13% compared with 50\u00b12% in controls; P&amp;lt;0.01) and the ratio of liver weight\/body weight increased (5.4\u00b10.2% compared with 4.7\u00b10.3% in the controls; P&amp;lt;0.01). Furthermore, in animals exposed to hypoxia, steatosis was more pronounced (P&amp;lt;0.01), and the NAS [NAFLD (non-alcoholic fatty liver disease) activity score] (8.3\u00b12.4 compared with 2.3\u00b110.7 in controls; P&amp;lt;0.01), serum AST, triacylglycerols and glucose were higher. Insulin sensitivity decreased in mice exposed to hypoxia relative to controls. The expression of the lipogenic genes SREBP-1c (sterol-regulatory-element-binding protein-1c), PPAR-\u03b3 (peroxisome-proliferator-activated receptor-\u03b3), ACC1 (acetyl-CoA carboxylase 1) and ACC2 (acetyl-CoA carboxylase 2) increased significantly in mice exposed to hypoxia, whereas mitochondria \u03b2-oxidation genes [PPAR-\u03b1 (peroxisome-proliferator-activated receptor-\u03b1) and CPT-1 (carnitine palmitoyltransferase-1)] decreased significantly. In conclusion, the findings of the present study demonstrate that hypoxia alone aggravates and accelerates the progression of NASH by up-regulating the expression of lipogenic genes, by down-regulating genes involved in lipid metabolism and by decreasing insulin sensitivity.<\/jats:p>","DOI":"10.1042\/cs20090313","type":"journal-article","created":{"date-parts":[[2009,10,16]],"date-time":"2009-10-16T14:55:10Z","timestamp":1255704910000},"page":"401-410","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN"],"prefix":"10.1042","volume":"118","author":[{"given":"Anne-Christine","family":"Piguet","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology and Visceral Research, University of Bern, CH-3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Stroka","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology and Visceral Research, University of Bern, CH-3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Zimmermann","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University of Berne, CH-3010 Berne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Dufour","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology and Visceral Research, University of Bern, CH-3010 Bern, Switzerland"},{"name":"Department of Visceral Surgery and Medicine, University of Berne, CH-3010 Berne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2009,12,14]]},"reference":[{"key":"2021113010171621000_B1","first-page":"568","article-title":"Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome","volume":"112","author":"Gastaut","year":"1965","journal-title":"Rev. Neurol. (Paris)"},{"key":"2021113010171621000_B2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1513\/pats.200708-139MG","article-title":"Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation","volume":"5","author":"Tasali","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"2021113010171621000_B3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.20725","article-title":"Chronic liver injury during obstructive sleep apnea","volume":"41","author":"Tanne","year":"2005","journal-title":"Hepatology"},{"key":"2021113010171621000_B4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1210\/er.2003-0031","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type\u00a01: a tissue-specific regulator of glucocorticoid response","volume":"25","author":"Tomlinson","year":"2004","journal-title":"Endocr. Rev."},{"key":"2021113010171621000_B5","doi-asserted-by":"crossref","first-page":"G871","DOI":"10.1152\/ajpgi.00145.2007","article-title":"Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver","volume":"293","author":"Savransky","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021113010171621000_B6","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI20513","article-title":"Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas","volume":"113","author":"Horie","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2021113010171621000_B7","doi-asserted-by":"crossref","first-page":"36380","DOI":"10.1074\/jbc.M213032200","article-title":"Hormone-sensitive lipase null mice exhibit signs of impaired insulin sensitivity whereas insulin secretion is intact","volume":"278","author":"Mulder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021113010171621000_B8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"2021113010171621000_B9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"2021113010171621000_B10","first-page":"1147","article-title":"Hematologic changes in mice during and after exposure to severe hypobaric hypoxia","volume":"46","author":"Huff","year":"1975","journal-title":"Aviat. Space Environ. Med."},{"key":"2021113010171621000_B11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2021113010171621000_B12","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1126\/science.1056843","article-title":"Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2","volume":"291","author":"Abu-Elheiga","year":"2001","journal-title":"Science"},{"key":"2021113010171621000_B13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.numecd.2008.12.015","article-title":"Hepatic lipid metabolism and non-alcoholic fatty liver disease","volume":"19","author":"Tessari","year":"2009","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"2021113010171621000_B14","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.95.8.4333","article-title":"ADD1\/SREBP1 activates PPAR\u03b3 through the production of endogenous ligand","volume":"95","author":"Kim","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010171621000_B15","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1128\/MCB.19.8.5495","article-title":"Regulation of peroxisome proliferator-activated receptor \u03b3 expression by adipocyte differentiation and determination factor 1\/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism","volume":"19","author":"Fajas","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"2021113010171621000_B16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1534-5807(02)00401-X","article-title":"The forkhead transcription factor Foxo1 regulates adipocyte differentiation","volume":"4","author":"Nakae","year":"2003","journal-title":"Dev. Cell"},{"key":"2021113010171621000_B17","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1128\/MCB.00200-09","article-title":"Hypoxia-inducible factor 2 regulates hepatic lipid metabolism","volume":"29","author":"Rankin","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"2021113010171621000_B18","doi-asserted-by":"crossref","first-page":"38052","DOI":"10.1074\/jbc.M106703200","article-title":"Amino acid and insulin signaling via the mTOR\/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells","volume":"276","author":"Tremblay","year":"2001","journal-title":"J. Biol. Chem."},{"key":"2021113010171621000_B19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1083\/jcb.200403069","article-title":"The TSC1-TSC2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins","volume":"166","author":"Harrington","year":"2004","journal-title":"J. Cell Biol."},{"key":"2021113010171621000_B20","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","article-title":"Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor","volume":"98","author":"Haase","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010171621000_B21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/hep.21593","article-title":"Chronic intermittent hypoxia predisposes to liver injury","volume":"45","author":"Savransky","year":"2007","journal-title":"Hepatology"},{"key":"2021113010171621000_B22","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1152\/japplphysiol.00522.2005","article-title":"Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice","volume":"99","author":"Li","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"2021113010171621000_B23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1113\/jphysiol.2003.048173","article-title":"Intermittent hypoxia increases insulin resistance in genetically obese mice","volume":"552","author":"Polotsky","year":"2003","journal-title":"J. Physiol."},{"key":"2021113010171621000_B24","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1164\/rccm.200610-1527OC","article-title":"Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity","volume":"175","author":"Iiyori","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021113010171621000_B25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.03.00089902","article-title":"Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome","volume":"22","author":"Meslier","year":"2003","journal-title":"Eur. Respir. J."},{"key":"2021113010171621000_B26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2265.2005.02407.x","article-title":"Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance","volume":"64","author":"Makino","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"2021113010171621000_B27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0009-2797(97)00075-6","article-title":"Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes","volume":"107","author":"Woodcroft","year":"1997","journal-title":"Chem-Biol. Interact."},{"key":"2021113010171621000_B28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0026-895X(25)08567-0","article-title":"Insulin down-regulates cytochrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line","volume":"47","author":"De\u00a0Waziers","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"2021113010171621000_B29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/0006-2952(89)90338-9","article-title":"Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1)","volume":"38","author":"Ekstrom","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"2021113010171621000_B30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510270121","article-title":"Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis","volume":"27","author":"Weltman","year":"1998","journal-title":"Hepatology"},{"key":"2021113010171621000_B31","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1074\/jbc.M410310200","article-title":"Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling","volume":"280","author":"Schattenberg","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021113010171621000_B32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI119248","article-title":"Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells","volume":"99","author":"Shimano","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2021113010171621000_B33","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1074\/jbc.274.42.30028","article-title":"Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus","volume":"274","author":"Shimomura","year":"1999","journal-title":"J. Biol. Chem."},{"key":"2021113010171621000_B34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0300-9084(97)81506-4","article-title":"Recent update on the PPAR\u03b1-null mouse","volume":"79","author":"Gonzalez","year":"1997","journal-title":"Biochimie"},{"key":"2021113010171621000_B35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-\u03b1, -\u03b2, and -\u03b3 in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"key":"2021113010171621000_B36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPAR\u03b1-leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"2021113010171621000_B37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: inflammation, NF-\u03baB and PPAR","volume":"544","author":"Vanden\u00a0Berghe","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021113010171621000_B38","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-8278(01)00066-6","article-title":"Diabetic KKAy mice exhibit increased hepatic PPAR\u03b31 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones","volume":"35","author":"Bedoucha","year":"2001","journal-title":"J. Hepatol."},{"key":"2021113010171621000_B39","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1210\/endo.141.11.7771","article-title":"Up-regulation of peroxisome proliferator-activated receptors (PPAR-\u03b1) and PPAR-\u03b3 messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-\u03b3-responsive adipose tissue-specific genes in the liver of obese diabetic mice","volume":"141","author":"Memon","year":"2000","journal-title":"Endocrinology"},{"key":"2021113010171621000_B40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1074\/jbc.M210062200","article-title":"Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor \u03b31 (PPAR\u03b31) overexpression","volume":"278","author":"Yu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021113010171621000_B41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI0215686","article-title":"The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation","volume":"110","author":"Nicolas","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2021113010171621000_B42","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.161296298","article-title":"Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease","volume":"98","author":"Fleming","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113010171621000_B43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/smrv.2002.0261","article-title":"Obstructive sleep apnoea syndrome\u2013an oxidative stress disorder","volume":"7","author":"Lavie","year":"2003","journal-title":"Sleep Med. Rev."},{"key":"2021113010171621000_B44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.gastro.2007.10.010","article-title":"PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-\u03baBp65\/mTOR-dependent mechanism","volume":"134","author":"Vinciguerra","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/118\/6\/401\/440460\/cs1180401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/118\/6\/401\/440460\/cs1180401.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T20:14:47Z","timestamp":1739391287000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/118\/6\/401\/68839\/Hypoxia-aggravates-non-alcoholic-steatohepatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,14]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,3,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20090313","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,14]]}}}